AgeneBio using over $3M in new funding to further develop Alzheimer’s drug

Check back often to find the latest news on AgeneBio and our pipeline of multiple candidates to treat patients with neurological and psychiatric disease.

« back to Press Releases

September 11, 2019

AgeneBio using over $3M in new funding to further develop Alzheimer’s drug

Coverage of our funding is available here.